Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,566,807 | 1,910,657 | 1,996,358 | 2,505,950 | 2,142,630 |
| Marketable Securities | 274,404 | 937,162 | 947,462 | 765,160 | 719,260 |
| Receivables | 3,387,878 | 2,941,500 | 2,347,315 | 1,747,320 | 1,515,550 |
| Inventories | 2,024,953 | 1,701,211 | 1,649,030 | 1,763,020 | 1,727,540 |
| Other current assets | 0 | 0 | 2 | 618,100 | 544,360 |
| TOTAL | $8,254,042 | $7,490,530 | $6,940,167 | $7,399,550 | $6,649,340 |
| Non-Current Assets | |||||
| PPE Net | 4,125,149 | 3,897,184 | 3,721,939 | 3,912,000 | 3,656,390 |
| Investments And Advances | 152,625 | 98,133 | 39,398 | 7,280 | 7,660 |
| Intangibles | 245,697 | 287,632 | 258,336 | 0 | 0 |
| Other Non-Current Assets | 962,642 | 753,541 | 387,764 | 773,190 | 634,559 |
| TOTAL | $5,486,113 | $5,036,490 | $4,407,437 | $4,692,470 | $4,298,609 |
| Total Assets | $13,740,150 | $12,527,020 | $11,347,600 | $12,092,050 | $10,947,970 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 128,376 | 38,292 | 86,400 | 65,600 | 306,670 |
| Accounts payable and accrued liabilities | 882,585 | 728,785 | 666,835 | 615,080 | 518,130 |
| Accrued Expenses | N/A | N/A | N/A | 218,850 | 223,230 |
| Other current liabilities | 4,501,718 | 3,151,658 | 2,883,341 | 2,984,040 | 2,246,220 |
| TOTAL | $6,006,749 | $4,314,473 | $3,739,046 | $3,883,590 | $3,294,270 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 93,820 | 89,860 |
| Other Non-Current Liabilities | 547,738 | 511,325 | 460,858 | 516,400 | 462,150 |
| TOTAL | $548,986 | $631,008 | $587,347 | $1,209,420 | $1,062,830 |
| Total Liabilities | $6,555,734 | $4,945,481 | $4,326,394 | $5,093,020 | $4,357,110 |
| Shareholders' Equity | |||||
| Common Shares | 94,499 | 97,955 | 96,768 | 108,400 | 106,980 |
| Retained earnings | 7,359,689 | 7,326,500 | 6,739,373 | 6,936,040 | 6,436,090 |
| Other shareholders' equity | -267,768 | 161,084 | 188,068 | -41,410 | 52,780 |
| TOTAL | $7,184,420 | $7,581,539 | $7,021,209 | $6,999,030 | $6,590,850 |
| Total Liabilities And Equity | $13,740,154 | $12,527,020 | $11,347,603 | $12,092,050 | $10,947,960 |